Octagon Capital Advisors as of June 30, 2023
Portfolio Holdings for Octagon Capital Advisors
Octagon Capital Advisors holds 41 positions in its portfolio as reported in the June 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Apellis Pharmaceuticals (APLS) | 33.2 | $239M | 2.6M | 91.10 | |
| Verona Pharma Sponsored Ads (VRNA) | 7.3 | $52M | 2.5M | 21.14 | |
| Cymabay Therapeutics | 7.0 | $50M | 4.6M | 10.95 | |
| Arcus Biosciences Incorporated (RCUS) | 5.6 | $40M | 2.0M | 20.31 | |
| Roivant Sciences SHS (ROIV) | 5.5 | $39M | 3.9M | 10.08 | |
| Mirati Therapeutics | 3.8 | $27M | 750k | 36.13 | |
| Celldex Therapeutics Com New (CLDX) | 3.6 | $26M | 760k | 33.93 | |
| Miragen Therapeutics (VRDN) | 3.1 | $22M | 923k | 23.79 | |
| Bridgebio Pharma (BBIO) | 2.9 | $21M | 1.2M | 17.20 | |
| 89bio (ETNB) | 2.8 | $20M | 1.1M | 18.95 | |
| Disc Medicine (IRON) | 2.6 | $18M | 415k | 44.40 | |
| Vir Biotechnology (VIR) | 2.2 | $16M | 650k | 24.53 | |
| Reneo Pharmaceuticals (RPHM) | 2.2 | $16M | 2.4M | 6.56 | |
| Tandem Diabetes Care Com New (TNDM) | 1.6 | $12M | 475k | 24.54 | |
| Aerovate Therapeutics (AVTE) | 1.5 | $11M | 622k | 17.15 | |
| Iteos Therapeutics (ITOS) | 1.1 | $7.9M | 596k | 13.24 | |
| Dyne Therapeutics (DYN) | 1.1 | $7.8M | 693k | 11.25 | |
| Insmed Com Par $.01 (INSM) | 1.1 | $7.7M | 367k | 21.10 | |
| Alpine Immune Sciences (ALPN) | 1.1 | $7.7M | 750k | 10.28 | |
| Travere Therapeutics (TVTX) | 1.1 | $7.6M | 495k | 15.36 | |
| Geron Corporation (GERN) | 1.0 | $7.3M | 2.3M | 3.21 | |
| Xilio Therapeutics (XLO) | 0.9 | $6.4M | 2.4M | 2.62 | |
| An2 Therapeutics (ANTX) | 0.9 | $6.1M | 721k | 8.50 | |
| Jasper Therapeutics | 0.9 | $6.1M | 4.5M | 1.37 | |
| Viking Therapeutics (VKTX) | 0.8 | $6.1M | 375k | 16.21 | |
| Annexon (ANNX) | 0.8 | $5.8M | 1.7M | 3.52 | |
| Glycomimetics (GLYC) | 0.7 | $5.2M | 3.0M | 1.74 | |
| Gossamer Bio (GOSS) | 0.7 | $4.7M | 4.0M | 1.20 | |
| Lexicon Pharmaceuticals Com New (LXRX) | 0.6 | $4.4M | 1.9M | 2.29 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 0.4 | $3.1M | 75k | 41.57 | |
| Pmv Pharmaceuticals (PMVP) | 0.4 | $2.9M | 470k | 6.26 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 0.4 | $2.5M | 412k | 6.19 | |
| Oric Pharmaceuticals (ORIC) | 0.3 | $2.1M | 277k | 7.76 | |
| Stoke Therapeutics (STOK) | 0.3 | $2.0M | 186k | 10.63 | |
| Iveric Bio Put Option | 0.3 | $2.0M | 50k | 39.34 | |
| Hepion Pharmaceuticals Com New (HEPA) | 0.2 | $1.6M | 155k | 10.50 | |
| Vera Therapeutics Cl A (VERA) | 0.2 | $1.1M | 70k | 16.05 | |
| Pieris Pharmaceuticals (PIRS) | 0.2 | $1.1M | 6.6M | 0.17 | |
| Magenta Therapeutics | 0.1 | $417k | 550k | 0.76 | |
| Inozyme Pharma (INZY) | 0.0 | $277k | 50k | 5.57 | |
| Monte Rosa Therapeutics (GLUE) | 0.0 | $136k | 20k | 6.85 |
